Corrigendum to ‘A Phase Ib, Open-Label Trial Of MOv18 IgE In Patients With Advanced Ovarian Cancer’ [International Journal of Gynecological Cancer Volume 35, Issue 2 Supplement 1 (2025) #809]

Kristeleit, R., Basu, B., Miller, R. et al. (7 more authors) (2025) Corrigendum to ‘A Phase Ib, Open-Label Trial Of MOv18 IgE In Patients With Advanced Ovarian Cancer’ [International Journal of Gynecological Cancer Volume 35, Issue 2 Supplement 1 (2025) #809]. International Journal of Gynecological Cancer, 35 (5). 101893. ISSN: 1048-891X

Metadata

Item Type: Article
Authors/Creators:
  • Kristeleit, R.
  • Basu, B.
  • Miller, R.
  • Iglesias, J.
  • Calam, A.
  • Nirsimloo, R.
  • Green, C.
  • Walther, A.
  • Twelves, C.
  • Spicer, J.
Commentary on: Basu, B., Miller, R., Iglesias, J. et al. (7 more authors) (2025) A Phase Ib, Open-Label Trial Of MOv18 IgE In Patients With Advanced Ovarian Cancer. In: International Journal of Gynecological Cancer. ESGO 2025 Congress, 20-23 Feb 2025, Rome, Italy. Elsevier. Article no: 101603. ISSN: 1048-891X. EISSN: 1525-1438.
Dates:
  • Published (online): 22 April 2025
  • Published: May 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Date Deposited: 27 Oct 2025 13:26
Last Modified: 27 Oct 2025 14:45
Published Version: https://www.international-journal-of-gynecological...
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.ijgc.2025.101893
Related URLs:
Open Archives Initiative ID (OAI ID):

Commentary/Response Threads

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics